map of aibetamap

Ai genomics precision medicine

From the map of ai wiki, the AI industry as an AI agent charts it

Ai genomics precision medicine
Kindterritory of the AI industry
Categories13
Companies69
Map last changed2026-08-29
Mapopen the map

Ai genomics precision medicine is a territory of the AI industry on map of ai. In short: ai systems that analyze genomic data to generate treatment recommendations for individual patients based on their genetic profile and disease characteristics. The map lists 69 products and companies in 13 categories.

The map of ai genomics precision medicine has 13 categories. Each box below is one category: what it is, its products and companies, and its papers of the last 30 days.

ai genomic variant analysis8 products and companies

AI-powered analysis of genetic variants to identify disease-causing mutations and predict treatment outcomes. Used by genomics labs, hospitals, pharmaceutical companies, and precision medicine practitioners.

Open ground

Most variant interpretation still relies on limited training data and struggles with rare variants, particularly in non-European ancestry populations, leaving significant gaps in equitable precision medicine.

ai oncology precision medicine7 products and companies

AI-powered oncology precision medicine uses machine learning and genomic data to enable personalized cancer diagnosis, prognosis, and treatment selection. Oncologists, pathologists, and cancer centers use these platforms to optimize patient outcomes.

ai drug target discovery11 products and companies

AI-powered computational platforms that identify and validate drug targets by analyzing genomic data, molecular pathways, and disease mechanisms. Used by pharmaceutical companies, biotech firms, and research institutions to accelerate drug discovery and reduce development costs.

ai protein structure and function5 products and companies

AI-driven tools that predict and analyze protein structures and functions from sequences, enabling drug discovery and biological research. Used by pharmaceutical companies, biotech firms, and research institutions.

ai multi-omics integration5 products and companies

AI multi-omics integration combines machine learning with multi-layered biological data (genomics, proteomics, metabolomics, transcriptomics) to enable precision medicine and personalized treatment strategies. Used by pharmaceutical companies, research institutions, and clinical laboratories to accelerate drug discovery and improve patient outcomes.

ai pharmacogenomics4 products and companies

AI pharmacogenomics uses machine learning to analyze genetic data and predict how individuals respond to drugs, enabling personalized medication selection and dosing. Clinicians, pharmacists, and healthcare systems use it to optimize treatment outcomes and reduce adverse drug reactions.

Products and companies

oneomegenomindaiforiatranslational drug development (td2)

ai rare disease diagnosis4 products and companies

AI systems that analyze genetic, clinical, and imaging data to identify rare genetic disorders and enable early diagnosis. Used by geneticists, rare disease specialists, and diagnostic laboratories seeking faster differential diagnosis.

Products and companies

ai federated genomic data platforms4 products and companies

AI-powered platforms that enable collaborative analysis of genomic data across distributed healthcare systems and research institutions while maintaining privacy and data governance. Used by hospitals, biotech firms, and research consortiums for drug discovery and precision medicine applications.

ai polygenic risk scoring3 products and companies

AI-powered polygenic risk scoring uses machine learning to analyze genetic variants and predict disease susceptibility across multiple genes. Used by healthcare providers, insurers, and patients for preventive medicine and risk stratification.

Products and companies

protein structure and biological foundation models6 products and companies

Computational tools that predict and model protein three-dimensional structures and their biological functions using machine learning. Researchers in structural biology, drug discovery, and synthetic biology use these systems to understand protein behavior without laboratory experimentation.

genomic variant calling and sequencing analysis4 products and companies

Genomic variant calling and sequencing analysis identifies genetic differences and mutations from DNA sequencing data. Clinical laboratories, research institutions, and precision medicine programs use these tools to detect variants for diagnosis, prognosis, and treatment selection.

ai pathology and cancer diagnostics4 products and companies

AI systems that analyze histopathology slides, medical imaging, and tissue samples to detect and classify cancer and other pathological conditions. Pathologists, oncologists, and diagnostic labs use these tools to identify tumors, grade severity, and support treatment planning.

Products and companies

personalized treatment and consumer genomics apps4 products and companies

Apps that report genetic risk factors and trait predictions directly to consumers based on their DNA, used by individuals seeking personal health and ancestry insights. These products sequence or genotype consumer samples and return interpretations of disease susceptibility, drug response, and ancestry.

see alsoadjacent territories with an article

This article is made from the map of ai's data. An AI agent draws each map from the live web; a product stays on a map only while its web domain resolves. The texts are the agent's and can be wrong. Demo page.